A. Hussain

发表

Development and Validation of a Novel HPLC Method to Analyse Metabolic Reaction Products Catalysed by the CYP3A2 Isoform: In Vitro Inhibition of CYP3A2 Enzyme Activity by Aspirin (Drugs Often Used Together in COVID-19 Treatment)

D. Naughton, James Barker, A. Hussain, 2022, Molecules.

Modified iodimetric determination of echothiophate iodide.

A. Hussain, B. Kho, C. Warner, 1971, Journal of pharmaceutical sciences.

Nasal absorption of propranolol in humans.

T. Kashihara, A. Hussain, S. Hirai, 1979, Journal of pharmaceutical sciences.

Solubility enhancement of some water-insoluble drugs in the presence of nicotinamide and related compounds.

A. A. Rasool, L. Dittert, A. Hussain, 1991, Journal of pharmaceutical sciences.

Quantitative spectrophotometric methods for determination of sodium hypochlorite in aqueous solutions.

A. Hussain, A. Repta, P. Trudell, 1970, Journal of pharmaceutical sciences.

Kinetics and mechanism of decomposition of N-chloroamino acids. II: conformationally restricted models.

P. Crooks, A. Hussain, R. Awad, 1990, Journal of pharmaceutical sciences.

Kinetics and mechanism of hydrolysis of 1-(2'-acetoxybenzoyl)-2-deoxy-alpha-D-glucopyranose, a novel aspirin prodrug.

A. Hussain, H. Kostenbauder, J. Truelove, 1979, Journal of pharmaceutical sciences.

Effect of hydroxyl group substituents on pyran ring on hydrolysis rate of benzoates: 2-tetrahydropyranyl benzoate.

A. Hussain, J. Truelove, 1979, Journal of pharmaceutical sciences.

Kinetics of hydrolysis of acylals of aspirin: hydrolysis of (1'-ethoxy)ethyl 2-acetoxybenzoate.

A. Hussain, J. Truelove, M. Yamasaki, 1974, Journal of pharmaceutical sciences.

Effect of complex formation between 4-hexylresorcinol and ethyl myristate on release rate of 4-hexylresorcinol from petrolatum base.

T. Kashihara, K. Iga, A. Hussain, 1981, Journal of pharmaceutical sciences.

New direct calculation of K1:1 and K1:2 complexation constants using solubility method.

T. Kashihara, K. Iga, A. Hussain, 1981, Journal of pharmaceutical sciences.

Sensitive method for determination of ethinyl estradiol in presence of norethindrone.

A. Hussain, S. Hirai, S. Babhair, 1980, Journal of pharmaceutical sciences.

Prodrug approaches to enhancement of physicochemical properties of drugs IX: acetaminophen prodrug.

D. Perrier, A. Hussain, P. Kulkarni, 1978, Journal of pharmaceutical sciences.

First-pass metabolism of ethinyl estradiol in dogs and rats.

A. Hussain, S. Hirai, R. Smith, 1981, Journal of pharmaceutical sciences.

Prodrug approaches to enhancement of physicochemical properties of drugs IV: novel epinephrine prodrug.

A. Hussain, A. Hussain, J. Truelove, 1976, Journal of pharmaceutical sciences.

Is aspirin phenylalanine ethyl ester a prodrug for aspirin?

A. Hussain, Z. Muhi-eldeen, 1983, Journal of pharmaceutical sciences.

Nasal absorption of 17α‐ethinyloestradiol in the rat

P. Crooks, A. Hussain, R. N. BAWARSHI‐NASSAR, 1989 .

Prediction of dissolution rates of slightly water-soluble powders from simple mathematical relationships.

A. Hussain, 1972, Journal of pharmaceutical sciences.

Prodrug approach to enhancement of rate of dissolution of allopurinol.

A. Hussain, J. Rytting, 1974, Journal of pharmaceutical sciences.

New spectrophotometric determination of inorganic bromide and chloride salts in aqueous solutions.

A. Hussain, R. Bawarshi, 1979, Journal of pharmaceutical sciences.